Key Features
Policy Studies for Market Access
Conducts detailed policy studies to enhance the licensing, pricing, and reimbursement processes. Focuses on effectively communicating the disease, indication, and product benefits to positively influence evaluations.
Public-Industry Alternative Working Models
Develops alternative study models that promote compliance and efficacy, benefiting both public entities and pharmaceutical companies. Provides consultancy services tailored to support reimbursement decisions for innovative drugs.
Social Responsibility Programs
Designs programs to expedite patient access to innovative medicines, like the OESS Program aimed at engaging pharmaceutical companies. Ensures the social responsibility initiatives align with patient needs and industry standards.
Start-Up Projects
Offers consultancy for licensing, pricing, and reimbursement decisions, along with market analysis and distribution strategies. Tailors support to specific market needs, tax regulations, and investment opportunities.
Expert Opinion and Health Data Management
Utilizes focus groups for data acquisition and interpretation, aiding in market share analysis and model adaptation. Develops digital health solutions, including user-friendly databases and platforms for healthcare management.
Pharmacoeconomic Model Adaptation
Adapts global models to local data, enhancing relevance and applicability to specific markets. Ensures comprehensive consideration of local healthcare dynamics in pharmacoeconomic evaluations.
Reimbursement Application Strategy
Crafts strategies for reimbursement applications across various diseases and therapeutic areas. Manages the complete process from file preparation to evaluation.